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1. Organization of the USJCMSP
US-Japan Cooperative Medical Science Program (USJCMSP) was initiated in 1965 uh-
der the agreement between the summit of two countries, then Prime Minister of Japan Mr.
E. Satoh and then president of the US Mr. L. Johnson. The aim of the program was to in-
itiate cooperative research between the two countries on diseases prevalent in Asia. Joint
delegation committee was organized in both countries consisting of biomedical experts and
administrators, and five joint research panels were formed under the program, namely,
cholera, leprosy, parasitic diseases, tuberculosis and viral diseases. The joint committee met
once a year either in the US or in Japan, and the Sub-committee on Program Review and
Planning met twice, once immediately before the joint committee meeting and another one
mtemediately in Hawaii, usually in January or February.
Each panel consists of five panel members including its chair from both sides and some
25 collaborative researchers in case of Japan, and research activities of each panel are carreid
out according to the guideline set for each panel by the joint committee. The guideline could
be revised according to the recommendation of the joint committee. Each panel held the joint
research conference annually and alternately in Japan and in the US. The budget of the
USJCMSP of the Japanese side includes research grant, travel expense for the joint research
conference, dispatch of scientisits to the US and Asia.
2. Development of t九e USJCMSP
In 1966, the malnutrition panel was newly added considering the serious nuturitional
situation in Asian countries. In 1970, five years after the initiation of the program, it was
decided to carry out review on panel research activities, and in 1971, the guideline for the
review was approved, and actual review was initiated on leprosy and parasitic diseases
panels. In 1971, it was also recommended to establish a new panel on environmental muta-
genesis and carcinogenesis panel taking into account the deterioration of environmental sitひ
ation in Asian countreis in accordance with the economic development, in particular the
progress of industrialization, and in 1972, it was agreed to create a new panel on environ-
mental mutagenesis and carcinogenesis.
In 1977, the name of the cholera panel was changed to the cholera and related diarrheal
diseases panel as the results of the review of panel activities because research had been ex-
panded to toxins of E. coli causing diarrhea similar to cholera.
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It was also suggested to create a new independent panel on hepatitis as it was a serious
problem in most Asian countries though it was caused by viruses. In 1978, a joint symposium
on hepatitis was held in conjuction with the joint committee, and after hearing presentations
in the symposium, it was recommended to create a new panel on hepatitis. The Japanese
translation of the malnutrition panel was changed from ``low nutritional status" to "abnormal
nutritional status", as the research activities of the panel started to cover such problems as
obesity. In 1979, a new panel on hepatitis was established.
In 1980, a symposium on immunology was held in conjuction with the joint committee
meeting, as there had been a marked progress in the research on immunology, and such a
progress had been applied in the research activities of each panel. In 1981, the new im-
munology board was established. Administratively, the delegation committee is under the
jurisdiction of the Ministriy of Foreign Affairs, the panels are under the Ministry of Health
and Welfare, and the new immunology board is under the Ministry of Education, Culture and
sports, and the budget is provided separately by these ministries.
In 1988, the new panel on AIDS was established considering the serious situation of
HIV/AIDS. In 1993, a workshop on acute respiratory infection was held, as ARI and diarrhea
were two top killers in most developing countries and the former was not yet included in the
USJCMSP. A workshop on ARI was held again in 1994, and a -rkshop on measles was
held in 1995. Hearing presentations and discussions in these workshops, it was felt necessary
to create a new panel on ARI, however, it was difficult to increase the number of panels
under the financial situation of Japan. In 1996, the TB and leprosy panels were amalgamated
into one TB and leprosy panel and a new panel on ARI was established. D也ng the transition
period for five years, the TB and leprosy panel had two cochairs on each side and the
number of panel members and collaborative researchers is larger than the ordinary panel,
however, it will be reduced to normal size within five years.
In 1997, the name of malnutrition panel was changed to the nutrition and metabolism
panel as diabetes mellitus became one of serious problems in developing countries and it
should be included in the activities of the panel.
In July 1998, a workshop on immunity and infection was held in conjunction with the
joint committee meeting, and interesting overview was made on the topic. The name of the
cholera and related diarrheal diseases was changed to the cholera and other enteric bacterial
infection panel as viral diarrhea is studied in the viral diseases panel.
3. Emerging and re-emerging infectious diseases and the US∬CMSP
In April 1996, during the summit talk of the Prime Minister of Japan Mr R Hashimoto
and the president of the US Mr B Clinton, it was agreed to included a topic of emerging
infectious diseases into the common agenda between two countries, and the USJCMSP was
mandated to cope with this topic from scientific aspect.　､
In July 1996. the first international conference on emerging infectious diseases in the
pacific rim was held in Kyoto soon after the joint committee meeting held in Hiroshima un-
der the sponsorship of the USJCMSP, and the overview was made on major emerging and
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re-emerging infectious diseases. As big epide中c of EHEC 0-157 was ongoing in Japan dur-
mg this time, the mass media of Japan showed keen interest on this topic.
In March 1997, the second international conference on emerging infectious diseases in
the Pacific rim was held in Bangkok under the sponsorship of the USJCMSP, and topics
discussed during this conference were dengue and dengue haemorrhagic fever, infection with
EHEC O-157 and resistance to antimicrobials. It was possible to invite some research workers
from Asian countries to this conference.
In March 1998, the third international conference on emerging infectious diseases in the
Pacific rim was held in Denpasar, Bali. Topics discussed were malaria, TB, hepatitis and the
relationship between the infection and malignancy. It was possible to invite much more par-
ticipants from Asian countries than the last year.
How major emerging and re-emerging infectious diseases are dealt in the panels of the
USJCMSP could be summarized as follows:
Cholera and other enteric bacterial infection panel: Active joint research activities are
made on the infection with EHEC 0-157 and a new strain of vibrio cholerae 0-139.
TB and leprosy panel: TB is a typical re-emerging infection, and active research is
carried out on the development of rapid diagnostic methods and molecular level mechanism of
tub erculoi mmunity.
Viral diseases panel: Ebola haemorrhagic fever is one of typical emerging infections,
however, it is rather difficult to study it in Japan. Dengue and dengue haemorrhagic fever is
a typical re-emerging infection, and active research is ongoing under the USJCMSP.
Parasitic diseases panel: Malaria is also one of important re-emerging diseases, and the
emphasis of research is focussed on the development of a new vaccine.
Environmental mutagenesis and carcinogenesis panel‥ Helicobacter /さylori infection is one
of emerging infections, and its relation with not only the emergence of gastric ulcer but also
on gastric cancer is a hot area for research.
Hepatitis panel: Hepatitis viruses E and C are newly identified, and studies on these
new viruses are ongoing.
AIDS panel: HIV/AIDS is one of typical emerging infections, and active researches are
ongoing including the development of new vaccines and drugs. HTLV-1 is also a new virus
isolated in Japan, and it is investigated in this panel.
4. Role played by也e USJCMSP for researches in tropical diseases
During 1960s and 1970s, interest on tropical diseases were reduced in Japan due to the
rapid decrease of the diseases, and many departments of parasitology or infectious diseases
were closed in the medical school. Under such circumstanses, the U.SJCMSP contributed to
maintain research capability for tropical diseases. If there were no USJCMSP, much more
departments on parasitology or infectious diseases might disappear from the medical school.
Each panel held joint research conference with the US panel every year, and this was
a good occasion to expose young Japanese scientists to the international world and encourage
them to participate more actively in the research on tropical diseases.
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Real collaboration in research has been made between scientists of two countries by
exchanging bacterial strains, antigens and other materials, and conducting complementary
researches.
Through the communication program under the USJCMSP, Japanese scientists had a
chance to visit the US or Asian countries to observe and discuss about the ongoing resear-
ches on tropical diseases. It is our regret that the communication and exchanges of scientists
are one-sided, mostly from Japan to the US, and it is our wish to invite more US scientists
to work with us in Japan.
A地ough our target are diseases prevalent in Asia, it was rather difficult to involve
Asian scientists to the USJCMSP mainly due to insufficient research grant, however, m a
recent few years after the introduction of the emerging infectious diseases to the ITSJCMSP,
it has become possible to invite several Asian scientists and health administrators to the
symposium, and we are now considering to initiate the collaborative research on emerging
and re-emerging infectious diseases with Asian scientists.
5. Major a血ievements of也e USJCMSP on tropical diseases
cholera and other enteric bacterial infection panel: Development of oral rehydration
therapy, characterization of cholera toxin and its application to the development of vaccine,
and studies on EHEC 0-157 and vibrio cholerae 0-139.
Hepatitis panel: Identification of hepatitis viruses C and E, the production of vaccine
against hepatitis B, and studies on the treatment of chronic hepatitis B, C and D by alpha
interferon.
Tuberculosis and leprosy panel: Elucidation of cellular and molecular mechanism of
tuberculoimmunity, new methodologies in molecular epidemiology such as RFLP, develop-
ment of animal models for leprosy and multi-drug therapy.
AIDS panel: Development of in situ PCR and other single cell techniques which enabled
to detect a large number of CD4+ lymphocytes and monocyte/macrophages infected with
HIV virus. Advances in the development of chemotherapy and vaccines for HIV infection.
Environmental mtitagenesis and carcinogenesis panel: Development and application of
new animal models and shorトterm tests to screen new mutagens and carcinogens and their
identification, monitoring mutagens and carcinogens in human population, and studies on in-
teraction between cancer and infections.
viral diseases panel: Development of a new vaccine against rabies, field trial of
preventing dengue and dengue haemorrhagic fever, and studies on viral gastroenteritis.
parasitology panel: Demonstration of the role of cytokines in protective immunity and
disease progression during parasitic infections, and identification of defined recombinant
and/or synthetic antigens that induce protective immunity against malaria, schistosomiasis
and filariasis.
6. Future direction of the USJCMSP relating to research in tropical diseases.
since 1998, a new budget was mandated to the Japanese delegation of the USJCMSP
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through the Ministry of Health and Welfare in addition to the regular budget. This budget is
called the supporting budget for the internationally priority strategic research, and its aim is
to support priority research under the USJCMSP, thus to promote health of Asian people.
The budget could be used for the following activities:
1) To sponsor international conference on emerging and re-emerging infectious diseases,
2) To prepare for the above conference,
3) To support researches on priority topics, and
4) To dispatch Japanese experts overseas or to invite foreign researchers if urgently needed.
Through this budget, it has become possible for each panel to use approximately 1
million Yen for each year for collaborative research with Asian scientists on priority topics.
Though the amount of research grant is very small, if we could show excellent achivements
in this collaborative research, it might be possible further to increase the budget in the fu-
ture.
